- TypeWebinar
- Location San Diego, California, United States
- Date 12-01-2017
Education/Teaching/Training/Development
Advertising/Marketing
Manufacturing
Business Development
OVERVIEW:
The US Food and Drug Administration has recently released information about its new strategies as a result of the new administration.
The new commissioner recently announced a new policy for Warning Letters and FDA-483 responses, putting manufacturers under very tight response timelines. The CDRH director recently retired under a cloud of complaints from center scientists about device approvals being too friendly to manufacturers. More inspectors are taking to the field to attack the backlog of inspections, and FDA is once again pushing third party inspections as another strategy to reduce backlog. The commissioner is speaking about returning to the mission of the agency, protecting the public health, All of these changes bring uncertainty to device approvals and the ability of manufacturers to keep products on the market.
Product Id : 501066
Instructor : David Dills
Areas Covered in the seminar:
Who Will Benefit:
IMPORTANT DATE:
Webinar Date:Â Thursday, January 12, 2017 | 10:00 AM PST | 01:00 PM EST
Duration: 90 Minutes
For more details and updates please visit website
Netzealous LLC DBA - Compliance4All 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA.
18004479407